SEC Filings for Fate Therapeutics Inc. (FATE)

$ 13.63   -1.05 (-7.15%) Volume: 584.46k 4:00 PM EDT Oct 18, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities110/16/2019
4Statement of changes in beneficial ownership of securities110/16/2019
4Statement of changes in beneficial ownership of securities110/16/2019
4Statement of changes in beneficial ownership of securities110/16/2019
SC 13D/A[Amend] General statement of acquisition of beneficial ownership809/17/2019
4Statement of changes in beneficial ownership of securities109/17/2019
8-KCurrent report pursuant to Section 13 or 15(d)6009/12/2019
424B5Prospectus [Rule 424(b)(5)]6709/12/2019
424B5Prospectus [Rule 424(b)(5)]6609/11/2019
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)1008/07/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)6308/06/2019
8-KCurrent report pursuant to Section 13 or 15(d)1108/06/2019
4Statement of changes in beneficial ownership of securities108/02/2019
4Statement of changes in beneficial ownership of securities108/02/2019
4Statement of changes in beneficial ownership of securities107/30/2019
<<
First
<
Prev
123456789101112131415